RPS4XP10

Across TCGA pan-cancer cohorts, RPS4XP10 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPS4XP10’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RPS4XP10 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPS4XP10 is over-expressed in tumor.

KIRC, BRCA, and COAD are the cancer types where RPS4XP10 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPS4XP10 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	All	+0.079	<.001	8	view →
BRCA	All	II,III,IV	+0.131	<.001	6	view →
COAD	All	All	+0.087	.003	5	view →
STAD	All	All	+0.106	.019	4	view →
HNSC	All	All	+0.068	.022	2	view →
LUSC	All	II,III,IV	+0.064	.045	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

RPS4XP10–KIRC

Open the KIRC breakdown →